Federal officials say a man from El Salvador has died at a New Jersey immigration jail. The jail has been targeted for months by protesters over living conditions for people detained there. U.S. Immigration and Customs Enforcement said Monday that Edwin Lopez-Cornejo had been held at Delaney Hall in Newark after being arrested in June. The agency says he died Saturday. The government accused Lopez-Cornejo of entering the U.S. illegally. His official cause of death has not been released. His death has prompted immediate and fierce condemnation from officials and community members. President Donald Trump and his deputies have defended the center’s operations.

Lindsay Clancy's murder trial is in the second week of testimony about the killings of her three children in a coastal Massachusetts town in 2023. Court was back in session Monday after a week of wrenching testimony and a jury trip to the home where the children were strangled. Monday’s witnesses have so far included doctors who provided medical treatment to Clancy and two of her children, building on testimony some of their colleagues gave for the prosecution last week. Clancy’s defense says she was a loving mother who was overmastered by postpartum psychosis. Prosecutors contend that she acted intentionally and should be held criminally responsible.

A Massachusetts mother who strangled her three young children and tried to kill herself sobbed in court as jurors listened to her then-husband's anguished 911 call from that day. The trial focuses on Lindsay Clancy’s mental state, with her lawyers arguing she had postpregnancy psychosis. Prosecutors say she acted intentionally and is criminally responsible for the deaths in January 2023. Patrick Clancy also gave a second day of testimony Wednesday about his family's last ordinary hours and his wife’s deteriorating mental health. He has said in interviews that he views her as ill, rather than evil. If convicted, she faces life in prison. If found not guilty, she could be committed to a mental health facility.

After the United States slashed its foreign aid funding last year, more than 280,000 aid workers worldwide lost their jobs. Most of those workers live outside the U.S., in conflict zones or poor areas where other job opportunities are scarce. In impoverished Nepal, where a conservative culture leaves openly transgender people with few legal job options, the impact on aid workers’ lives was crushing. Starving and scared, around 100 LGBTQ+ aid workers left jobless by the funding cuts have turned to sex work to survive, walking the streets alongside the very people they once fought so hard to help.

The Ebola outbreak in eastern Congo is the fastest-growing one in history and responders are struggling to keep up. Over 2,400 cases, including just under 1,000 deaths, have been confirmed. Strikes by unpaid workers at health centers could spark further unrest, even as a study has begun of two badly needed treatments. This type of Ebola has no approved treatments or vaccines. Cases are spreading to new areas of Congo and the World Health Organization says most new cases are emerging from unknown chains of transmission. The outbreak is complicated by rebels and misinformation, as some people claim Ebola isn't real.

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol. The drug cleared Thursday can lower dangerous cholesterol in a way that’s previously only been available with expensive, injectable drugs. The Lipfendra pill from Merck is the first noninjectable option for blocking a liver protein that interferes with the body’s ability to clear cholesterol from the blood. Biotech injectables targeting the protein have been available from other drugmakers for more than a decade. But patient access has been limited by high prices, insurance restrictions and low prescribing by doctors.

Health officials serving under President Donald Trump want to make it easier for men to get a prescription for testosterone. It's the latest shift in an ongoing debate over the benefits and risks of boosting the hormone. Defense Secretary Pete Hegseth announced this week that the military would begin screening for low testosterone and offering the hormone to troops. That approach follows the advice of some men's health influencers, who promote testosterone as an all-purpose formula for strength and vitality. Experts disagree with that assessment. But they do say new evidence supports testosterone's benefits for sexual problems like erectile dysfunction and low libido.